Cargando…
The potential crosstalk between tumor and plasma cells and its association with clinical outcome and immunotherapy response in bladder cancer
BACKGROUND: Although immunotherapy is effective in improving the clinical outcomes of patients with bladder cancer (BC), it is only effective in a small percentage of patients. Intercellular crosstalk in the tumor microenvironment strongly influences patient response to immunotherapy, while the cros...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155334/ https://www.ncbi.nlm.nih.gov/pubmed/37138324 http://dx.doi.org/10.1186/s12967-023-04151-1 |
_version_ | 1785036305847025664 |
---|---|
author | Long, Fei Wang, Wei Li, Shuo Wang, Bicheng Hu, Xin Wang, Jun Xu, Yaqi Liu, Min Zhou, Junting Si, Huaqi Xi, Xiaodan Meng, Xiang-yu Yuan, Chunhui Wang, Fubing |
author_facet | Long, Fei Wang, Wei Li, Shuo Wang, Bicheng Hu, Xin Wang, Jun Xu, Yaqi Liu, Min Zhou, Junting Si, Huaqi Xi, Xiaodan Meng, Xiang-yu Yuan, Chunhui Wang, Fubing |
author_sort | Long, Fei |
collection | PubMed |
description | BACKGROUND: Although immunotherapy is effective in improving the clinical outcomes of patients with bladder cancer (BC), it is only effective in a small percentage of patients. Intercellular crosstalk in the tumor microenvironment strongly influences patient response to immunotherapy, while the crosstalk patterns of plasma cells (PCs) as endogenous antibody-producing cells remain unknown. Here, we aimed to explore the heterogeneity of PCs and their potential crosstalk patterns with BC tumor cells. METHODS: Crosstalk patterns between PCs and tumor cells were revealed by performing integrated bulk and single-cell RNA sequencing (RNA-seq) and spatial transcriptome data analysis. A risk model was constructed based on ligand/receptor to quantify crosstalk patterns by stepwise regression Cox analysis. RESULTS: Based on cell infiltration scores inferred from bulk RNA-seq data (n = 728), we found that high infiltration of PCs was associated with better overall survival (OS) and response to immunotherapy in BC. Further single-cell transcriptome analysis (n = 8; 41,894 filtered cells) identified two dominant types of PCs, IgG1 and IgA1 PCs. Signal transduction from tumor cells of specific states (stress-like and hypoxia-like tumor cells) to PCs, for example, via the LAMB3/CD44 and ANGPTL4/SDC1 ligand/receptor pairs, was validated by spatial transcriptome analysis and associated with poorer OS as well as nonresponse to immunotherapy. More importantly, a ligand/receptor pair-based risk model was constructed and showed excellent performance in predicting patient survival and immunotherapy response. CONCLUSIONS: PCs are an important component of the tumor microenvironment, and their crosstalk with tumor cells influences clinical outcomes and response to immunotherapies in BC patients. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-023-04151-1. |
format | Online Article Text |
id | pubmed-10155334 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101553342023-05-04 The potential crosstalk between tumor and plasma cells and its association with clinical outcome and immunotherapy response in bladder cancer Long, Fei Wang, Wei Li, Shuo Wang, Bicheng Hu, Xin Wang, Jun Xu, Yaqi Liu, Min Zhou, Junting Si, Huaqi Xi, Xiaodan Meng, Xiang-yu Yuan, Chunhui Wang, Fubing J Transl Med Research BACKGROUND: Although immunotherapy is effective in improving the clinical outcomes of patients with bladder cancer (BC), it is only effective in a small percentage of patients. Intercellular crosstalk in the tumor microenvironment strongly influences patient response to immunotherapy, while the crosstalk patterns of plasma cells (PCs) as endogenous antibody-producing cells remain unknown. Here, we aimed to explore the heterogeneity of PCs and their potential crosstalk patterns with BC tumor cells. METHODS: Crosstalk patterns between PCs and tumor cells were revealed by performing integrated bulk and single-cell RNA sequencing (RNA-seq) and spatial transcriptome data analysis. A risk model was constructed based on ligand/receptor to quantify crosstalk patterns by stepwise regression Cox analysis. RESULTS: Based on cell infiltration scores inferred from bulk RNA-seq data (n = 728), we found that high infiltration of PCs was associated with better overall survival (OS) and response to immunotherapy in BC. Further single-cell transcriptome analysis (n = 8; 41,894 filtered cells) identified two dominant types of PCs, IgG1 and IgA1 PCs. Signal transduction from tumor cells of specific states (stress-like and hypoxia-like tumor cells) to PCs, for example, via the LAMB3/CD44 and ANGPTL4/SDC1 ligand/receptor pairs, was validated by spatial transcriptome analysis and associated with poorer OS as well as nonresponse to immunotherapy. More importantly, a ligand/receptor pair-based risk model was constructed and showed excellent performance in predicting patient survival and immunotherapy response. CONCLUSIONS: PCs are an important component of the tumor microenvironment, and their crosstalk with tumor cells influences clinical outcomes and response to immunotherapies in BC patients. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-023-04151-1. BioMed Central 2023-05-03 /pmc/articles/PMC10155334/ /pubmed/37138324 http://dx.doi.org/10.1186/s12967-023-04151-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Long, Fei Wang, Wei Li, Shuo Wang, Bicheng Hu, Xin Wang, Jun Xu, Yaqi Liu, Min Zhou, Junting Si, Huaqi Xi, Xiaodan Meng, Xiang-yu Yuan, Chunhui Wang, Fubing The potential crosstalk between tumor and plasma cells and its association with clinical outcome and immunotherapy response in bladder cancer |
title | The potential crosstalk between tumor and plasma cells and its association with clinical outcome and immunotherapy response in bladder cancer |
title_full | The potential crosstalk between tumor and plasma cells and its association with clinical outcome and immunotherapy response in bladder cancer |
title_fullStr | The potential crosstalk between tumor and plasma cells and its association with clinical outcome and immunotherapy response in bladder cancer |
title_full_unstemmed | The potential crosstalk between tumor and plasma cells and its association with clinical outcome and immunotherapy response in bladder cancer |
title_short | The potential crosstalk between tumor and plasma cells and its association with clinical outcome and immunotherapy response in bladder cancer |
title_sort | potential crosstalk between tumor and plasma cells and its association with clinical outcome and immunotherapy response in bladder cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155334/ https://www.ncbi.nlm.nih.gov/pubmed/37138324 http://dx.doi.org/10.1186/s12967-023-04151-1 |
work_keys_str_mv | AT longfei thepotentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT wangwei thepotentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT lishuo thepotentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT wangbicheng thepotentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT huxin thepotentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT wangjun thepotentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT xuyaqi thepotentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT liumin thepotentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT zhoujunting thepotentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT sihuaqi thepotentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT xixiaodan thepotentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT mengxiangyu thepotentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT yuanchunhui thepotentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT wangfubing thepotentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT longfei potentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT wangwei potentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT lishuo potentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT wangbicheng potentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT huxin potentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT wangjun potentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT xuyaqi potentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT liumin potentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT zhoujunting potentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT sihuaqi potentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT xixiaodan potentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT mengxiangyu potentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT yuanchunhui potentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer AT wangfubing potentialcrosstalkbetweentumorandplasmacellsanditsassociationwithclinicaloutcomeandimmunotherapyresponseinbladdercancer |